Article Details
Retrieved on: 2025-09-04 21:10:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Enveda Biosciences has raised $300 million over the last year to make drugs to treat atopic dermatitis, asthma and more.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here